CD4 and neoplasm: Tumor analysis revealed that the response to ICPi often correlates with the pre-existence of an immunologically privileged tumor microenvironment characterized by the presence of CD4/CD8 T cells, immune checkpoints, and pro-inflammatory cytokines [28,29].